FUJIFILM Corporation (President: Kenji Sukeno) announces the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan® Tablet” (generic name: favipiravir) for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus. Avigan, approved in Japan for manufacture and sale as an influenza antiviral drug, […]
FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet” (generic name: favipiravir) in Japan for patients of COVID-19, a respiratory infection caused by the novel Coronavirus (SARS-CoV-2). Following the rapid and global outbreak […]
FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet” (generic name: favipiravir) in Japan for patients of COVID-19, a respiratory infection caused by the novel coronavirus (SARS-CoV-2). Following the rapid and global outbreak […]
Covid-19 Update from Peter Faulhaber, Fujifilm Recording Media U.S.A. President and CEO
To Our Valued Customers: First and foremost, I trust that you and your family are well during this unprecedented pandemic. On March 23, 2020, Charles D. Baker, the Governor of the Commonwealth of Massachusetts, issued COVID-19 Executive Order No. 13. The Executive Order requires all businesses and organizations that do not provide “Essential Services” to […]
We can help you reduce cost, decrease vendor lock-in, and increase productivity of storage staff while ensuring accessibility and longevity of data.
Contact Us >